Activists are pushing the government to “march in” and break the pharma giant’s Truvada patent.
Their promise is tantalizing: end the HIV epidemic without a vaccine. But how? In an op-ed published this week in The New York Times, two prominent HIV activists and a physician argue “the solution comes in a pill” — albeit a very expensive one.
“Taken daily, Truvada, the brand name for a type of pre-exposure prophylaxis, or PrEP, is up to 99 percent effective at preventing H.I.V. infection,” the op-ed states. “Used as directed, it’s one of the most effective methods of preventing a viral infection ever discovered, as good as the polio vaccine, the miracle of modern medicine.”
The op-ed’s authors — Peter Staley, James Krellenstein and Dr. Aaron Lord — say the problem is not enough of the at-risk population is taking PrEP. They blame “poor policy” and “pharmaceutical price-gouging” for making PrEP “a luxury rather than an imperative,” and they have a plan to change this.
In an interview with NBC News, longtime HIV activist Peter Staley said the plan, aptly dubbed #BreakThePatent, is centered on pushing Gilead Sciences, the manufacturer of Truvada, to either lower the drug’s price or allow a generic manufacturer to sell PrEP in the U.S.
Staley said a national PrEP program could end the HIV epidemic in the U.S. but said it would cost billions of dollars a year unless the price of the drug was significantly reduced.
When Truvada was approved as PrEP in 2012, a month’s supply cost roughly $1,200. The price has inched up in the six years since, and today, the average retail price in a U.S. pharmacy is about $2,000 a month, according to GoodRx. In almost every other country, generic Truvada is available for less than $100 a month. Representatives from Gilead, however, say most Americans on PrEP receive the pills for free by using their insurance and copay assistance cards.
Earlier this year, the Centers for Disease Control and Prevention (CDC) estimated 1.1 million Americans are “at substantial risk for HIV and should be offered PrEP.” While the number of people taking Truvada has increased steadily in the U.S. since it was first approved for prevention purposes, recent data provided by Gilead Sciences estimates just 167,000 people are currently taking the drug.
Those at substantial risk for HIV, according to the CDC, include HIV-negative people in sexual relationships with HIV-positive partners, injection drug users, and men who have sex with men and do not always use condoms. Earlier this week, UNAIDS estimated that globally men who have sex with men are 28 times more likely to acquire HIV than their heterosexual counterparts.
In cities that have robust HIV prevention programs and make PrEP easily accessible — like New York, San Francisco and Washington, D.C. — the number of new HIV diagnoses has consistently decreased since 2012.
New York City overhauled its sexual health clinics and created “HIV one stops,” considered the gold standard in HIV prevention. Instead of delaying the start of PrEP or HIV treatment, a person can walk out of the clinic with a bottle of Truvada the very same day. But Staley said this comes at a cost: New York’s program is borrowing from other health programs, he said, and it is still “busting their budget.”
If everyone in that at-risk group were to start PrEP tomorrow, Staley said, new HIV cases would crash, and the epidemic would grind to a halt in the U.S. But he and other activists say they have waited six years since Truvada was first approved for prevention purposes, and so far, less than 10 percent of the people who should be on PrEP are taking the daily pill.
Staley said the idea for the #BreakThePatent movement was spawned a little over a year ago after the Food and Drug Administration made an unexpected decision.
“The FDA shocked all of us by approving Teva Pharmaceutical to make a generic Truvada,” Staley said. “None of us saw that coming, and the FDA was telling us that generic Truvada would be on store shelves within a few weeks.”
But that never happened. In American pharmacies, the only PrEP drug currently available is the one manufactured by Gilead: Truvada.
When the generic never materialized, activists from PrEP4All, the group behind the #BreakThePatent movement, spoke to patent experts and discovered a little-known aspect of the Bayh-Dole Act of 1980, also known as the Patent and Trademark Law Amendments Act. This aspect of the legislation, called “march-in rights,” provides a method for the government to break the exclusivity of a patent.
March-in rights allow the government to require a patent holder “to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a responsible applicant or applicants” if “such action is necessary to alleviate health or safety needs which are not reasonably satisfied” by the patent holder.
Staley, a co-founder of PrEP4All, said march-in rights could be applied to Gilead, which he said is not reasonably satisfying the need to stem the HIV epidemic.
The federal government and private donors, like the Gates Foundation, footed most of the bill for the research and development that went into PrEP, according to a 2018 report by AVAC, a global HIV advocacy and prevention organization. This is one of the reasons Staley and other activists argue the company should not have the exclusive rights to the drug.
And, since President Trump has said lowering drug prices is one of his “greatest priorities,” and many other politicians on both sides of the aisle have spoken out about drug price inflation, Staley said there may be a window of opportunity to find partners in the current Republican administration, even if it means sticking it to Gilead.
“It’s not lost on AIDS activists that probably the best AIDS president was George W. Bush,” he said, referring to Bush’s signature President’s Emergency Plan for AIDS Relief (PEPFAR) program that provides reduced-price HIV treatments to people in low-income countries around the world.
While three experts told NBC News they had never heard of “march-in rights” being used by the government, James Love, director of Knowledge Ecology International, a nonprofit that works on access to affordable medicine, said “there’s definitely a chance that the tide is going to turn on the march-in issue.”
“It could be this case, it might be the next case, but someone is going to start winning these cases,” Love said.
In a statement provided to NBC News, Gilead Sciences said feedback from patients does not suggestion “cost is a primary obstacle to treatment.”
“The majority of people receiving Truvada for PrEP today who utilize our co-pay coupons pay less than $5 per bottle, and our co-pay assistance program is sufficient to meet the needs of the large majority of people who use it,” according to the statement. “We encourage anyone facing financial difficulties to contact us at www.GileadAdvancingAccess.com.”
The company did not respond to NBC News’ questions regarding the #BreakThePatent movement, Truvada’s price increases and Gilead’s contribution to the research and development funding for PrEP.
Check out the original story here: NBC Out.
Tags: #BigBankChallenge #BohemianKissChallenge #EqualityActJapan #StopAsianHate 2020 Olympics Aaron Schock Adam Castillejo Adam Rippon addiction ageism Aging AhTave AIDS Aime Wichtendal Alaska Alex Morse Almost Love America's Next Top Model American Medical Association Amy Coney Barrett Annise Parker Antes Que El Mundo Se Acabe Anti-Asian Violence Anti-LGBTQ ANTM anxiety Aptima HIV-1 Arizona Armie Hammer astrology At-home date Atlanta Atlanta Black Pride Atlanta Nightlife Atlanta Pride Atlanta Pride Run Austin Swink Austin Texas Backpacks for the Street Basel Abou Hamrah BFI Flare Bisexual BLACK GAY MEN Black LGBTQ Atlanta Black Lives Matter Black Love Bohemian Rhapsody Boston Boston MA Brian Sims Broadway bully Bullying California Call Me By Your Name Canada Capital Pride Capitalism Cason Crane Celebrity News censorship Chemistry Chemsex Chicago Chicago IL Chris Evans Christian proselytizing Christianity Christmas Christmas movie Christmas Movies Chucky Circus of Books civil unions Cody McCook Colorado Comedy coming out commentary compatibility Confidence Congress conspiracy theory Conversion therapy CoronaVirus COVID COVID-19 Covid-19 vaccine daddy Dallas Dallas Gay Bars Dallas Gayborhood Dallas Texas Danica Roem Daniel Harding Daniel Howell Date night dating Dating Apps dating rut dating tips DC Pride Dead to Me Denver Depression discrimination Disney Documentary Dolf Pasker Dolly Parton Domestic Violence Donald Trump Donna Price Drag Race drag racing Dustin Lance Black election Election 2020 Election Day Elite Employment Entertainment Entertainment news epidemic Fabio Fasoli Family family gatherings Film Finding True Love First Date First Date Etiquette first date ideas first date tips Flirting Tips Flirty Dancing Florida Fort Lauderdale Franklin Graham Freddie Mercury Garrett Clayton gay gay asian gay asian men Gay Atlanta Gay Bars NYC Gay beaches Gay Boston Gay Chicago Gay Couple Gay Couples Gay Culture Gay Dallas Gay Dallas Nightlife gay dating gay dating advice gay dating app gay dating apps Gay Dating Solutions Gay Dating Tips Gay DC gay discrimination gay film Gay Florida Gay Fort Lauderdale Gay Health Gay Holiday Movie Gay Houston gay kiss Gay Love Advice gay marriage gay marriage proposal gay men Gay Miami gay midlife Gay Mountaineer Gay Movies Gay New York Gay Nurse Gay NYC Gay Panic Gay Pride gay relationship advice gay relationship tips gay relationships Gay Scene gay seniors gay sex gay singles Gay Soldier Gay Travel Gay Twitter Gay Washington DC Gay Wedding gay weddings Gay Widower Gays Over COVID gaysian Gen Z Generation Z Georgia Gert Kasteel Ghosting GLAAD GOP Gorsuch Guy Vandenberg Gym Gays Haaz Sleiman Hallmark Halloween Hate Crime Health HGVT HIV HIV prevention HIV stigma HIV treatment HIV vaccine HIV/AIDS hobbies Holi-date Holiday Film Holiday Movies Holidays Hollywood Holyoke Homophobia hooking up hookup hookup culture Hot Vax Summer House Hunters Houston Texas Houston TX Hulu Ian Jordan Indya Moore Instagay Instagram intersex Intimacy Iowa Iowa caucus isolation It's A Sin Jake Gyllenhaal James Bushe Japan Jaymes Vaughan Jayson Conner Jeffrey Newman Jennifer Tilly Jewish Jewish persecution Joe Biden Jonathan Bennett Josef Salvat Jussi-Pekka Kajaala Justice Ruth Bader Ginsburg JVN Jwan Yosef Karamo Brown Kristine Stolakis Lady Gaga Lesbian lesbian couple Let It Snow LGBT LGBT Travel Guide LGBT-Free Zones LGBTQ LGBTQ Asians LGBTQ Atlanta LGBTQ Boston LGBTQ Chicago LGBTQ Dallas LGBTQ discrimination LGBTQ employees LGBTQ Family LGBTQ Film LGBTQ Film Festival LGBTQ Films LGBTQ flag LGBTQ Fort Lauderdale LGBTQ Health LGBTQ Houston LGBTQ Miami LGBTQ movies LGBTQ New York LGBTQ NYC LGBTQ Pride LGBTQ retirees LGBTQ retirement LGBTQ Rights LGBTQ Seniors LGBTQ Victory Institute LGBTQ Youth Life Lifetime Lifetime TV Network Linda Warren lockdown London LGBTIQ+ Film Festival loneliness Love Victor Luke Evans Male Nurse Malik Brown marriage equality marriage proposal Marsha P Johnson Marvel Marvin Cortes Massachusetts mature gay dating mental health Mexico Miami Miami Beach Miami Beach Pride Miami Florida Michael Cashman Michael Henry Middle-aged gay men midlife Modern Family mormon Mr. Right Muscle gays music video My Gay Match NASCAR National Coming Out Day Nationwide Conversion Therapy Ban Neil Gorsuch Netflix Netflix Special Nevada New Year's Resolution New York New York City Nonbinary North Dakota Northern Ute tribe Nurse Appreciation Week NYC NYC Events NYC Pride NYC Pride 2021 Oak Lawn Obergefell v. Hodges older gay man Omander Omar Ayuso One True Pairing online dating online dating apps online dating tips online gay dating Online trolls Open Relationship Operation Hyacinth OTP Outfest Outfest LA 2021 Outfest Los Angeles Pan-African Pride pandemic Paper Moons Pat Robertson Pennsylvania Perez Hilton personality personality type Pete Buttigieg Pink Capitalism Poland Politics polyamorous polyamorous relationship polyamorous relationships Pope Francis Pose power bottom Pray Away PrEP pride Pride 2021 Pride Afrique Pride Flag Pride Month Prince Harry profile pic Puerto Vallarta quarantine Queer eye Queer Film Queer Films Queer Holiday Movies Queer Lawmakers Queer Love Story Queer Santa Queer Youth racism Rafa Olarra Rainbow Wave Reddit Relationship relationship advice Relationship Tips relationships religion Rep. Andy Biggs Republican retirement Ricky Martin rom-com Romantic Comedy Ryan Murphy Ryan O’Connell Samaritan’s Purse same sex marriage Same Sex Relationships Same Sex Wedding Same-Sex Couples Same-Sex Kiss same-sex marriage ban Schitt’s Creek Score Miami Score Nightclub Scott Evans Scott Wiener Section 28 self isolation self-care Senior Gay Dating Senior Gay Men senior gays Senior Prom Seven Summits sex Sex Education sex life sexual identity sexual preference sexual racism sexuality short film Shy Gay Guys Single All the Way single gay man Single Gay Men Single Gays Single Young Gays social distancing social isolation social media Social Security Somerville sports Stonewall Stonewall Riots straight men Super Bowl ads Super Bowl commercials Super Bowl LIV Supreme Court Switzerland Syfy Syria Tan France Television Tennessee The Boys in the Band The Center on Colfax The Christmas Setup The Eternals The First The Thing About Harry Threesome throuple TikTok Tom Daley toxic masculinity Transgender Travel Travis Shumake true love Trump administration Turner Free TV series Tweets Twitter Unconditional Love United Methodist Church US economy US Supreme Court Valentine's day viral video Virginia Washington DC Web Series Wedding Workplace workplace discrimination World AIDS Day World Pride young gay men Youth YouTube